AI Emerges as Potential Solution to Science Misinformation Crisis

From research to multimedia content creation, artificial intelligence is fundamentally transforming how knowledge is generated and shared across industries. While some experts worry this trend could fuel misinformation through AI-generated content lacking proper verification, others see promising opportunities—particularly in fields where accurate communication is most critical.

For medicine and science, the impact of AI on communications has become an urgent concern. Recent years have witnessed a troubling rise in scientific misinformation, most notably during the COVID-19 pandemic, which significantly undermined healthcare credibility, vaccine confidence, and public trust in medical professionals.

This communication challenge is particularly crucial for life sciences and biopharmaceutical industries, where addressing medical misinformation directly affects public engagement and patient access to new treatments.

However, contrary to widespread concerns, emerging research suggests AI could help rebuild scientific trust. A recent study published in PNAS Nexus argues that AI-generated summaries actually enhance public understanding of science while portraying scientists more favorably than traditional communication methods.

Francine Carrick, a veteran with over two decades in science communication, views AI not as a threat but as an opportunity. “We’re at this incredible inflection point where evolving regulations, increasingly complex data, and the rise of AI are fundamentally reshaping how we communicate science,” Carrick has noted in industry discussions.

After nearly seven years leading business and client strategy at Envision Pharma Group, Carrick joined BCB Group as Managing Director for Medical Communications in 2024, later transitioning to Chief Commercial Growth Officer for private equity-backed ventures. Her extensive experience has provided deep insight into the barriers limiting effective medical communication.

“What excites me most is that AI isn’t just speeding things up, it has the potential to make medical communications more precise, more accessible, and more impactful than ever before,” says Carrick. “Imagine publications that adapt in real time to new evidence, or tools that help authors surface insights buried in mountains of clinical data. We’re just scratching the surface.”

This vision is materializing as Carrick assumes the presidency of Prezent Vivo, aiming to democratize AI access across the life sciences industry. Previously recognized as a healthcare leader by Inventive Health for her strategic leadership, Carrick now brings her expertise to establish Prezent Vivo as a reliable AI solution for life sciences companies and communication agencies.

The industry has historically struggled with implementing AI tools that maintain scientific depth and accuracy, often resorting to traditional agencies despite their slower processes due to specialization requirements. Prezent Vivo addresses this gap by combining a customized large language model with domain expertise.

“I joined Prezent Vivo because I dreamt of a solution that would let the best people in MedComms bring more value to their clients,” explains Carrick. “MedComms is undergoing a real transformation, and the agencies I’ve admired most are the ones asking how to elevate their experts.”

The platform’s key innovation lies in its dual capabilities. First, its Astrid AI is specifically designed for life sciences communication, trained on brand compliance requirements, regulatory language, clinical evidence structures, and strategic context. This technology is complemented by human domain experts, including presentation engineers, medical communications specialists, and writers who provide scientific judgment and strategic narrative development.

By combining these elements, Prezent Vivo enables the industry to leverage AI-powered communication at scale without compromising precision or regulatory compliance. The platform delivers a comprehensive range of content across the full product lifecycle—from congress posters and scientific documents to advisory board materials and sales meetings.

For pharmaceutical companies, Prezent Vivo promises cost reductions of 35-85% compared to traditional agencies. Importantly, the platform isn’t positioned to replace medical communications agencies but to enhance their capabilities, allowing them to triple project volume per writer without additional staffing.

As misinformation continues to challenge scientific communication, Prezent Vivo represents an emerging approach to how AI might help amplify expert voices while improving patient engagement. By addressing the compliance and accuracy concerns that have previously limited AI adoption in life sciences, the platform offers a glimpse into how technology could strengthen rather than undermine trusted scientific communication.